REG - Malin Corp PLC - Capital Markets Day

MalinAnnouncement

03/10/2018 07:05

RNS Number : 8047C
Malin Corporation PLC
03 October 2018
 


Malin Corporation plc
("Malin" or "the Company")
Capital Markets Day
 
Dublin-Ireland, 3 October 2018: Malin Corporation plc, a company investing in high-growth opportunities in the global healthcare sector, today announces it will host a Capital Markets Day event in London for analysts and investors on Thursday 8 November 2018.
 
Malin's executive team and Board will provide an update on the Company's vision and strategy, followed by an update from key investee companies, including:
 
·    Poseida Therapeutics
·    Immunocore
·    Kymab
·    Viamet
 
Invitations and a detailed agenda will follow. The event will take place at the London Stock Exchange, 10 Paternoster Row, London EC4M 7LS, commencing at 13.30pm with a networking lunch.
 
 
 
 
Ends
 
 
 
Contacts:
 
Malin
Darragh Lyons, CFO
Tel: +353 1 901 5700
 
Davy Corporate Finance (ESM Adviser)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
 
Powerscourt (Ireland PR)             Consilium Strategic Communications (UK PR)
Jack Hickey                                            Mary-Jane Elliott / Jonathan Birt
Tel: +353 83 4488339                       Tel: +44 (0)20 3709 5700
info@powerscourt-group.com        malin@consilium-comms.com
 
About Malin Corporation Plc
Malin (ISE:MLC) is a company investing in high-growth opportunities in the global healthcare sector. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science, with a proven, sustainable business model. Formed in 2015, Malin works with its diverse portfolio of investee companies, providing strategic and financial support to enable them to reach their value potential. Malin, with a strong leadership team and Board, is headquartered and domiciled in Ireland and listed on Euronext Dublin, with offices in London and a global investment focus. For more information visit www.malinplc.com 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFSASIDFASEDS